Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.10p
   
  • Change Today:
      0.10p
  • 52 Week High: 28.00
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 138.07m
  • Volume: 153,430
  • Market Cap: £20.85m
  • RiskGrade: 594

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.5  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%
30-Jun-25 n/a (3.06) (2.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Company Announcements

Appointment of Joint Corporate Broker 30-Oct-2025 07:00 RNS
Preliminary Results for Year Ended 30 June 2025 23-Oct-2025 07:00 RNS
Update on toxicology study for SDC-1801 10-Oct-2025 07:00 RNS

Sareum Holdings ShareCast News

Sareum halts toxicology study after control-grou... 10-Oct-2025 ShareCast
Sareum starts toxicology studies for lead inhibi... 29-May-2025 ShareCast
Sareum shares drop on product licence termination 31-Dec-2024 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 15.10p
Change Today 0.10p
% Change 0.69 %
52 Week High 28.00
52 Week Low 11.25
Volume 153,430
Shares Issued 138.07m
Market Cap £20.85m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Price Trend
27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 05-Nov-2025

Time Volume / Share Price
14:00 100,000 @ 15.00p
14:00 20,000 @ 15.00p
14:00 80,000 @ 15.00p
11:51 1,703 @ 14.68p
10:52 10,000 @ 15.14p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page